Pfizer profit doubles, but anti-smoking drug sags (Reuters)
Date : 23 Jul 2008 Category : Business
Reuters - Pfizer Inc on Wednesday said
quarterly earnings more than doubled on higher sales of its
prescription drugs and lower expenses, but its Chantix
quit-smoking drug lost more than a third of its U.S. sales amid
safety concerns.